| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A recombinant human protein fragment (within amino acids 314-410) was used as the immunogen for the Carbonic Anhydrase IX antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
Carbonic Anhydrase IX Antibody / CAIX / CA9 is an antibody targeting Carbonic. Host: Mouse. Monoclonal. Clone: CA9/4019. Format: Purified. Applications: IHC-P.
Key elements and design rationale
- Target: Carbonic.
- Immunogen: A recombinant human protein fragment (within amino acids 314-410) was used as the immunogen for the Carbonic Anhydrase….
- Species reactivity: Human.
- Localization: Cell Surface, Cytoplasm.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
Carbonic Anhydrase IX catalyzes the interconversion between carbon dioxide and water and the dissociated ions of carbonic acid (i.e. bicarbonate and hydrogen ions). [UniProt]
Common research applications
- IHC: tissue distribution assessment; interpret with matched controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
